linaclotide

  1. T

    Constella® (Linaclotide), The First Approved Prescription Therapy In A New Class Of T

    Almirall, S.A. (ALM:MC) and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced the launch of Constella® (linaclotide 290mcg capsules once daily), the first approved prescription therapy in a new class of treatments for adults suffering from moderate to severe IBS-C[i], in Europe. Constella®...
  2. T

    Linzess (Linaclotide) For IBS With Constipation Or Chronic Idiopathic Constipation No

    Linzess (linaclotide), a medication for irritable bowel syndrome (IBS) with constipation or chronic idiopathic constipation is now available in American pharmacies, Ironwood Pharmaceuticals Inc. and Forest Laboratories Inc announced. The FDA (Food and Drug Administration) recently approved the...
  3. T

    Linaclotide Given Positive CHMP Opinion For Irritable Bowel Syndrome With Constipatio

    Almirall, S.A. (ALM:MC) and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) have announced that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the marketing approval for Constella® (linaclotide 290 micrograms), for the symptomatic...
Back
Top